Big Four firm Deloitte announced that it has acquired substantially all the assets from cloud ERP/HCM automation platform ...
Cytokinetics is advancing aficamten, a potential competitor to Camzyos, targeting hypertrophic cardiomyopathy (HCM). Strategic licensing deals with Sanofi and Bayer secure resources and focus US ...